 NEW HAVEN, Conn., July 28, 2021 GLOBE NEWSWIRE -- BioXcel Therapeutics, Inc. BioXcel or the Company NASDAQ: BTAI, a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced it will release its second quarter 2021 financial results on Tuesday, August 10, 2021 before the open of the U.S. financial markets. BioXcels management team will also host a conference call and webcast at 8:30 AM EDT to discuss the Companys financial results and to provide a general business update. 